Davis, M.P.; Ulrich, A.; Segal, R.; Gudena, V.; Ruddy, K.J.; D’Andre, S.; Giridhar, K.V.; Vasireddy, V.K.; Agarwal, R.; Azzouqa, A.-G.;
et al. Treatment of Established Chemotherapy-Induced Neuropathy with N-Palmitoylethanolamide: A Randomized, Double-Blind Phase II Pilot Study. Cancers 2024, 16, 4244.
https://doi.org/10.3390/cancers16244244
AMA Style
Davis MP, Ulrich A, Segal R, Gudena V, Ruddy KJ, D’Andre S, Giridhar KV, Vasireddy VK, Agarwal R, Azzouqa A-G,
et al. Treatment of Established Chemotherapy-Induced Neuropathy with N-Palmitoylethanolamide: A Randomized, Double-Blind Phase II Pilot Study. Cancers. 2024; 16(24):4244.
https://doi.org/10.3390/cancers16244244
Chicago/Turabian Style
Davis, Mellar P., Angela Ulrich, Rebecca Segal, Vinay Gudena, Kathryn J. Ruddy, Stacy D’Andre, Karthik V. Giridhar, Vamsi K. Vasireddy, Rajiv Agarwal, Abdel-Ghani Azzouqa,
and et al. 2024. "Treatment of Established Chemotherapy-Induced Neuropathy with N-Palmitoylethanolamide: A Randomized, Double-Blind Phase II Pilot Study" Cancers 16, no. 24: 4244.
https://doi.org/10.3390/cancers16244244
APA Style
Davis, M. P., Ulrich, A., Segal, R., Gudena, V., Ruddy, K. J., D’Andre, S., Giridhar, K. V., Vasireddy, V. K., Agarwal, R., Azzouqa, A.-G., Novotny, P., McCue, S., Bauer, B., & Loprinzi, C. L.
(2024). Treatment of Established Chemotherapy-Induced Neuropathy with N-Palmitoylethanolamide: A Randomized, Double-Blind Phase II Pilot Study. Cancers, 16(24), 4244.
https://doi.org/10.3390/cancers16244244
